Cell Reprogramming & Therapeutics LLC

Funding and NIH signals

• NIH award NIH awarded $422K (SBIR Phase I 1R43GM165021-01, new, notice Aug 18, 2026); 2 NIH awards totaling $845K in the last 12 months. NIH RePORTER 1R43GM165021-01 (Aug 18, 2026)
  Evidence (2 events)

  • Aug 18, 2026 · NIH RePORTER 1R43GM165021-01
    Organization: CELL REPROGRAMMING AND THERAPEUTICS, LLC; City/State: GREENFIELD, WI; Project number: 1R43GM165021-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-18; FY total cost (award amount): 422285; Administering IC: National Institute of General Medical Sciences; Project title: Novel Cell Culture Supplement from Adipocyte-Origin Megakaryocytes and Platelets; Organization type: Domestic For-Profits
  • Aug 14, 2026 · NIH RePORTER 1R43GM161870-01A1
    Organization: CELL REPROGRAMMING AND THERAPEUTICS, LLC; City/State: GREENFIELD, WI; Project number: 1R43GM161870-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-08-14; FY total cost (award amount): 422285; Administering IC: National Institute of General Medical Sciences; Project title: Development of a Novel, Safe, Easily Standardized, and Cost-Effective Cell Growth Supplement for Diverse Cell Culture Applications; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals